← Back to Search

Antioxidant

Astaxanthin (12 mg) for Metabolic Syndrome (Astaxanthin Trial)

N/A
Waitlist Available
Led By Jeremy Pettus, MD
Research Sponsored by University of California, San Diego
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

Astaxanthin Trial Summary

This trial will test if astaxanthin, a natural compound found in many foodstuffs, can help improve regulation of glucose and fat metabolism in subjects with insulin resistance/glucose intolerance.

Eligible Conditions
  • Metabolic Syndrome

Astaxanthin Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in insulin sensitivity
Secondary outcome measures
Change in fasting glucose
Change in lipid control

Astaxanthin Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: Astaxanthin (12 mg)Active Control1 Intervention
Subjects will be given capsules containing a set oral dose of astaxanthin (12 mg) and instructed to take two capsules each morning after (up to 1 hr) the morning meal for a total of up to 24 weeks (168 days on study drug).
Group II: PlaceboPlacebo Group1 Intervention
Subjects will be given capsules containing placebo and instructed to take two capsules each morning after (up to 1 hr) the morning meal for a total of up to 24 weeks (168 days on study drug).

Find a Location

Who is running the clinical trial?

University of California, San DiegoLead Sponsor
1,121 Previous Clinical Trials
1,520,890 Total Patients Enrolled
7 Trials studying Metabolic Syndrome
450 Patients Enrolled for Metabolic Syndrome
Jeremy Pettus, MDPrincipal InvestigatorUCSD
1 Previous Clinical Trials
440 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Clinical Trial of Anti-oxidant Astaxanthin in Insulin-resistant Subjects
Jeremy Pettus, MD 2016. "Clinical Trial of Anti-oxidant Astaxanthin in Insulin-resistant Subjects". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03310359.
~4 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top